about
The global threat of antimicrobial resistance: science for interventionRisk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical featuresInoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology.Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).Uncoupling between core genome and virulome in extraintestinal pathogenic Escherichia coli.Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase.Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes.Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain.Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.Presence of quinolone resistance to qnrB1 genes and blaOXA-48 carbapenemase in clinical isolates of Klebsiella pneumoniae in Spain.Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications.Acquisition and cross-transmission of Staphylococcus aureus in European intensive care units.Corrigendum to "The global threat of antimicrobial resistance: science for intervention" [New Microbes New Infect 6 (2015): 22-29]Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation.National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isola[The Microbiolgy laboratory in nosocomial infection surveillance and control].Characterization of an outbreak due to CTX-M-15-producing Klebsiella pneumoniae lacking the blaOXA-48 gene belonging to clone ST405 in a neonatal unit in southern Spain.[Comparison of 3 methods for determining sensitivity to imipenem and meropenem in Acinetobacter baumannii with a carbapenem-heteroresistant phenotype].Neonatal sepsis caused by a CTX-M-32-producing Escherichia coli isolate.First report of NDM-1-producing clinical isolate of Leclercia adecarboxylata in Spain.Assessment of periodontal and opportunistic flora in patients with peri-implantitis.Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients.Assessment of a phenotypic algorithm to detect plasmid-mediated quinolone resistance in Enterobacteriaceae.Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).[Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi].Low prevalence of mcr-1 positive Enterobacteriaceae isolates in a health area.Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinants.[Molecular typing methods for infection monitoring and control].Increased raw poultry meat colonization by extended spectrum beta-lactamase-producing Escherichia coli in the south of Spain.Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli.Similarities between the genetic environments of blaCTX-M-15 in Escherichia coli from clinical and food samples from Spain and overseas travellers.Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat products.
P50
Q28083609-5715E89D-BB1E-418B-BFD2-32F2D668333EQ33827095-BA68A5AC-DFB3-40EE-A2F1-E75A0D47AB2DQ34412299-1AF9230D-17A0-43CF-8AC1-F2D7985FBC37Q36785886-27E3247B-4728-44BA-8FFF-2C6FE2F139A4Q37264353-4CBBEFFB-E9B2-45CD-BC11-6D727EC9D0B5Q38301142-9836F479-3A32-4CE1-91C5-1CC47DBB100BQ38930785-9D589695-B570-478A-983D-D861A6A5C005Q39054376-122BB7BC-2B3E-4D61-B306-04DE55ADD8B8Q39063637-7434EDF8-4EAD-4EA3-89F4-E2C083E570A2Q40848069-B107062C-B2DB-4757-967D-ADB4AEBDE1EEQ41039899-6814059D-1CB3-4066-86BD-C0D8546E150CQ41299425-7AFA4818-E73E-4193-B511-192DCCE4980FQ41440864-5BB4EA32-C871-4A5E-910E-033BD0425142Q41635996-E357A453-E1A6-44C8-98C6-0FCF1C1887E5Q41688964-1EEFAA40-6360-4596-9673-6B82C15730E0Q42218740-96334EC0-79B9-41FA-82A1-9CA768EB157FQ42244321-BEE0DBAD-9273-4C35-84E0-C34D4E96E814Q42608550-85091FBB-C990-48C8-8E66-45785A0F5207Q42767651-18A3D369-0B31-4635-8872-FD4001C3B185Q43112313-EEAD747F-68F9-46A2-AE44-BA5F1E5BD6DEQ43521824-7178C08A-EEC9-4A8B-BB97-95AD741F5DBEQ43866729-B1BCE24D-5ED1-412A-989C-6D7A7F2946BCQ44596882-E620EDED-6F36-4838-B026-33D846957CB5Q44799115-74C71373-6244-489D-9BE0-60FBA19E0D53Q46191327-63C62F98-5C7A-4784-B4EE-B00D8AA1C8C1Q46352619-DD0877FA-EC3D-4EB4-9A4B-23F03CF84E97Q46365502-955EF240-75FA-4448-ADD2-4B1F0012DB97Q46907398-6D82A303-5488-4213-BBEF-EC3095467611Q49913114-B5CB1D35-C917-47F0-99ED-61C10D362483Q50764905-E0357A9B-373C-4C3A-8DED-08649867CF58Q51175770-3DF83C63-11F9-4AC4-96E3-CC202C26F55FQ51179904-CC7094CA-0AAD-4106-ADDB-ADCF0DD5FF5DQ53929880-81126CB1-83F1-41E5-B532-1531DA3CB8E7Q54263768-418CB743-E4FD-47B6-B3EF-E53FAB314D3CQ54268827-3D87258D-E4FE-4D70-A8BF-645EC4D180D8Q54287294-114F4B05-D321-46CF-8189-CEE722C8860AQ54304174-B0EB4EF0-84D6-4204-8256-FF6F96D153E6Q54351100-933C9E85-0AAB-43E1-B028-320F4BBCB707Q54358594-573FD21C-343F-4418-B964-45C4595B14DCQ54359670-173706FF-2B5D-42C6-8E5D-FD7F313B18FA
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lorena López-Cerero
@ast
Lorena López-Cerero
@en
Lorena López-Cerero
@es
Lorena López-Cerero
@nl
Lorena López-Cerero
@sl
type
label
Lorena López-Cerero
@ast
Lorena López-Cerero
@en
Lorena López-Cerero
@es
Lorena López-Cerero
@nl
Lorena López-Cerero
@sl
altLabel
Lorena Lopez-Cerero
@en
Lorena López-Cerero
@en
prefLabel
Lorena López-Cerero
@ast
Lorena López-Cerero
@en
Lorena López-Cerero
@es
Lorena López-Cerero
@nl
Lorena López-Cerero
@sl
P106
P1153
55909204300
P21
P31
P496
0000-0001-8950-4384